一、文章
1.Junyu Xiang, Yuanli Ni, Jiajun Yu, Hui Sun, Zhiyun Gu, Ziyong Li, Tongwang Yang, Juan Feng, Li Su, Limei Liu, Jiatao Li, Jesus Prieto, Matías A. Ávila, Juanjuan Shan, Na Zhuang & Cheng Qian. MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis. Nature Cancer 2025,6(12):1955-1975， doi: 10.1038/s43018-025-01059-1. ( Corresponding author)
2.Zhiyun Gu#, Tongwang Yang#, Yuanli Ni, Yuanze Zhou*, Cheng Qian* and Na Zhuang*. PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration. Journal for ImmunoTherapy of Cancer 2025,13(12):e013079， doi: 10.1136/jitc-2025-013079. (Corresponding author)
3.Tongwang Yang*, Zhiyun Gu*, Juan Feng, Juanjuan Shan, Cheng Qian and Na Zhuang. Non-parenchymal cells: key targets for modulating chronic liver diseases. Frontiers in Immunology 2025, 16:1576739， doi: 10.3389/fimmu.2025.1576739. (Corresponding author)
4. Juan Feng*, Yongliang Liu*, Na Zhuang*, Zixuan Chai, Limei Liu, Cheng Qian, Jiatao Li, Juanjuan Shan. EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting. Vaccines 2023,11(2):320, doi: 10.3390/vaccines11020320. ( *co-first author)
5.Na Zhuang*, Zhiyun Gu*, Juan Feng*, Zixuan Chai, Juanjuan Shan, Cheng Qian. BEX1 mediates sorafenib resistance in hepatocellular carcinoma by regulating AKT signaling. Cellular Signalling 2023,108:110722, doi: 10.1016/j.cellsig.2023.110722.(First author)
6.冯娟，李佳涛，庄娜。CRISPR/Cas9 敲除内源 TCR 增强 TCR-T 细胞对 HPV16 阳性宫颈癌SiHa细胞的杀伤。中国肿瘤生物治疗杂志 2023, 30(5): 373-379.(通讯作者)
7.Han Yongchao, Zhuang Na, Wang Tao. Roles of PINK1 in regulation of systemic growth inhibition induced by mutations of PTEN in Drosophila.Cell reports 2021,34(12):108875， doi: 10.1016/j.celrep.2021.108875.
8.Zhuang N, Li L, Chen S, Wang T. PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control. Cell death &disease 2016, 7(12):e2501，doi: 10.1038/cddis.2016.396. (First author)
9.Wu K*, Liu J*, Zhuang N*, Wang T. UCP4A protects against mitochondrial dysfunction and degeneration in pink1/parkin models of Parkinson's disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014,28(12):5111-21, doi: 10.1096/fj.14-255802. (*co-first author)
二、承担和参与的科学研究项目
[1].国家自然科学基金青年项目，PINK1通过调控肿瘤内中性粒细胞促进肝癌对PD-L1抗体治疗耐受的分子机制研究（82101931）; 项目负责人（2022.1-2024.12）
[2].重庆市自然科学基金面上项目，PINK1通过改变肿瘤免疫微环境调控HCC对PD-L1抗体响应的分子机制研究（CSTB2024NSCQ-MSX0416）；项目负责人（2024.7-2027.6）
[3].重庆市自然科学基金博士后科学基金项目，BEX1失调促进HCC耐受Sorafenib治疗的机制研究（cstc2020jcyj-bshX0009）；项目负责人（2020.9-2022.8）
[4].重庆市医学科研青年拔尖人才项目（YXQN2025020）；项目负责人（2025.8-2028.7）
[5].重庆市科卫联合项目面上项目，靶向降解MLL-AF9纳米抗体的筛选优化及其在白血病治疗中的应用研究（2026MSXM035）；项目负责人（2026.1-2027.12）
三、相关奖励与荣誉
[1] 2025年重庆市医学青年拔尖人才
[2] 2023年重庆市科协岗位创新争先行动一等奖
